Young Li
Stock Analyst at Jefferies
(0.21)
# 4,250
Out of 4,910 analysts
6
Total ratings
33.33%
Success rate
-32.64%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Downgrades: Hold | $24 → $9 | $7.90 | +13.92% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $73.38 | +56.72% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.12 | +11.61% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $27.70 | +116.61% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $11.48 | +300.70% | 1 | Jul 16, 2021 |
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $7.90
Upside: +13.92%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $73.38
Upside: +56.72%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.12
Upside: +11.61%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $27.70
Upside: +116.61%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $11.48
Upside: +300.70%